During the past decade, Inamed Research GmbH & Co. KG conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inamed Research GmbH & Co. KG" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Pari Pharma GmbH" with 1 trials sponsored, "Sterna Biologicals GmbH & Co. KG" with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Inamed Research GmbH & Co. KG" are "Pulmonary Disease, Chronic Obstructive" (8 trials), "Asthma" (5 trials), "COPD" (1 trials), "Cystic Fibrosis" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Inamed Research GmbH & Co. KG" in a lesser frequency.

Most popular intervention types in "Inamed Research GmbH & Co. KG" are "Drug" (9 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Berodual HFA-MDI" (2 trials), "Berodual Respimat" (2 trials), "10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials) and "5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inamed Research GmbH & Co. KG" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Inamed Research GmbH & Co. KG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Inamed Research GmbH & Co. KG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inamed Research GmbH & Co. KG, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".